Cardiovascular Disease (CVD) Completed Phase 3 Trials for Liraglutide (DB06655)

Also known as: Cardio Vascular Disease / Cardiovascular Diseases / Cardio-vascular Disease / Cardiovascular Disease / Cardio-vascular Diseases / Diseases, Cardiovascular / Cardiovascular disease, unspecified / Heart diseases / Cardiovascular disorder / Cardiovascular disorder NOS / Disorder cardiovascular (NOS) / Cardiovascular disorder (NOS)

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02043054Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)Treatment